何(柏)良:港有條件實施「0+0」方案 促政府果斷與世界接軌
港大感染及傳染病中心總監何(柏)良在電臺節目表示,全球已有逾140個國家放寬入境限制,香港亦有條件實施「0+0」,促請政府果斷與世界接軌,又建議政府最好在本月內採購到二價疫苗,讓已接種兩劑疫苗超過半年的長者優先接種。
他解釋,新加坡出現涉及BA.2.75的個案已經兩個月,本港要應對涉及變異病毒株BA.2.75,最重要是推動疫苗接種,而不是拖慢「0+0」檢疫安排的推進;他擔心,市民或對於已打齊疫苗,仍然未能復常,無所適從,並對接種疫苗感猶疑。
何(柏)良表示,據新加坡經驗,BA.2.75未有增加重症及死亡風險,即使流入本港導致確診宗數反彈,認爲市民亦毋須過份擔心;他又指,相信部分人已打第二、三針人士正等候雙價疫苗,認爲政府最好在今年內、甚至本月內爭取到雙價疫苗來港,讓相關長者優先接種,對整體預防重症有很大幫助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.